nach oben

European Archives of Psychiatry and Clinical Neuroscience

Erschienen in:

01.12.2010 | Original Paper

The hypothalamic-pituitary-adrenal axis and serotonin abnormalities: a selective overview for the implications of suicide prevention

verfasst von: Maurizio Pompili, Gianluca Serafini, Marco Innamorati, Anne Maria Möller-Leimkühler, Giancarlo Giupponi, Paolo Girardi, Roberto Tatarelli, David Lester

Erschienen in: European Archives of Psychiatry and Clinical Neuroscience | Ausgabe 8/2010

Einloggen, um Zugang zu erhalten

Abstract

Suicidal behavior and mood disorders are one of the world’s largest public health problems. The biological vulnerability for these problems includes genetic factors involved in the regulation of the serotonergic system and stress system. The hypothalamic-pituitary-adrenal (HPA) axis is a neuroendocrine system that regulates the body’s response to stress and has complex interactions with brain serotonergic, noradrenergic and dopaminergic systems. Corticotropin-releasing hormone and vasopressin act synergistically to stimulate the secretion of ACTH that stimulates the biosynthesis of corticosteroids such as cortisol from cholesterol. Cortisol is a major stress hormone and has effects on many tissues, including on mineralocorticoid receptors and glucocorticoid receptors in the brain. Glucocorticoids produce behavioral changes, and one important target of glucocorticoids is the hypothalamus, which is a major controlling center of the HPA axis. Stress plays a major role in the various pathophysiological processes associated with mood disorders and suicidal behavior. Serotonergic dysfunction is a well-established substrate for mood disorders and suicidal behavior. Corticosteroids may play an important role in the relationship between stress, mood changes and perhaps suicidal behavior by interacting with 5-HT1A receptors. Abnormalities in the HPA axis in response to increased levels of stress are found to be associated with a dysregulation in the serotonergic system, both in subjects with mood disorders and those who engage in suicidal behavior. HPA over-activity may be a good predictor of mood disorders and perhaps suicidal behavior via abnormalities in the serotonergic system.

Isolated cells from different tissues, kept in cultures, maintain a cyclical pattern of their biochemical activities.

Aguilera G, Rabadan-Diehl C (2000) Vasopressinergic regulation of the hypothalamic-pituitary-adrenal axis: implications for stress adaptation. Regul Pept 96:23–29PubMedCrossRef

Ahrens B, Grof P, Moller HJ, Muller-Oerlinghausen B, Wolf T (1995) Extended survival of patients on long-term lithium treatment. Can J Psychiatry 40:241–246PubMed

Ahrens B, Muller-Oerlinghausen B, Schou M, Wolf T, Alda M, Grof E, Grof P, Lenz G, Simhandl C, Thau K, Vestergaard P, Wolfd R, Möller HJ (1995) Excess cardiovascular and suicide mortality of affective disorders may be reduced by lithium prophylaxis. J Affect Disord 33:67–75PubMedCrossRef

Ajdacic-Gross V, Bopp M, Sansossio R, Lauber C, Gostynski M, Eich D, Gutzwiller F, Rossler W (2005) Diversity and change in suicide seasonality over 125 years. J Epidemiol Community Health 59:967–972PubMedCrossRef

Antonijevic IA (2006) Depressive disorders—is it time to endorse different pathophysiologies? Psychoneuroendocrinology 31:1–15PubMedCrossRef

Appelhof BC, Huyser J, Verweij M, Brouwer JP, van Dyck R, Fliers E, Hoogendijk WJ, Tijssen JG, Wiersinga WM, Schene AH (2006) Glucocorticoids and relapse of major depression (dexamethasone/corticotropin-releasing hormone test in relation to relapse of major depression). Biol Psychiatry 59:696–701PubMedCrossRef

Arato M, Rihmer Z, Szadoczky E (1986) Seasonal influence on the dexamethasone suppression test results in unipolar depression. Arch Gen Psychiatry 43:813PubMed

Arato M, Banki CM, Bissette G, Nemeroff CB (1989) Elevated CSF CRF in suicide victims. Biol Psychiatry 25:355–359PubMedCrossRef

Asberg M, Thoren P, Traskman L, Bertilsson L, Ringberger V (1976) “Serotonin depression”—a biochemical subgroup within the affective disorders? Science 191:478–480PubMedCrossRef

10.

Asberg M, Nordstrom P, Traskman-Bendz L (1986) Cerebrospinal fluid studies in suicide. An overview. Ann N Y Acad Sci 487:243–255PubMedCrossRef

11.

Austin MC, Janosky JE, Murphy HA (2003) Increased corticotropin-releasing hormone immunoreactivity in monoamine-containing pontine nuclei of depressed suicide men. Mol Psychiatry 8:324–332PubMedCrossRef

12.

Avishai-Eliner S, Hatalski CG, Tabachnik E, Eghbal-Ahmadi M, Baram TZ (1999) Differential regulation of glucocorticoid receptor messenger RNA (GR-mRNA) by maternal deprivation in immature rat hypothalamus and limbic regions. Brain Res Dev Brain Res 114:265–268PubMedCrossRef

13.

Axelson DA, Doraiswamy PM, Boyko OB, Rodrigo Escalona P, McDonald WM, Ritchie JC, Patterson LJ, Ellinwood EH Jr, Nemeroff CB, Krishnan KR (1992) In vivo assessment of pituitary volume with magnetic resonance imaging and systematic stereology: relationship to dexamethasone suppression test results in patients. Psychiatry Res 44:63–70PubMedCrossRef

14.

Bale TL, Vale WW (2004) CRF and CRF receptors: role in stress responsivity and other behaviors. Annu Rev Pharmacol Toxicol 44:525–557PubMedCrossRef

15.

Bale TL, Contarino A, Smith GW, Chan R, Gold LH, Sawchenko PE, Koob GF, Vale WW, Lee KF (2000) Mice deficient for corticotropin-releasing hormone receptor-2 display anxiety-like behaviour and are hypersensitive to stress. Nat Genet 24:410–414PubMedCrossRef

16.

Banki CM, Arato M (1983) Amine metabolites and neuroendocrine responses related to depression and suicide. J Affect Disord 5:223–232PubMedCrossRef

17.

Banki CM, Arato M, Papp Z, Kurcz M (1983) The effect of dexamethasone on cerebrospinal fluid monoamine metabolites and cortisol in psychiatric patients. Pharmacopsychiatria 16:77–81PubMedCrossRef

18.

Banki CM, Karmacsi L, Bissette G, Nemeroff CB (1992) Cerebrospinal fluid neuropeptides in mood disorder and dementia. J Affect Disord 25:39–45PubMedCrossRef

19.

Bao AM, Swaab DF (2007) Gender difference in age-related number of corticotropin-releasing hormone-expressing neurons in the human hypothalamic paraventricular nucleus and the role of sex hormones. Neuroendocrinology 85:27–36PubMedCrossRef

20.

Bao AM, Hestiantoro A, Van Someren EJ, Swaab DF, Zhou JN (2005) Colocalization of corticotropin-releasing hormone and oestrogen receptor-alpha in the paraventricular nucleus of the hypothalamus in mood disorders. Brain 128:1301–1313PubMedCrossRef

21.

Bao AM, Meynen G, Swaab DF (2008) The stress system in depression and neurodegeneration: focus on the human hypothalamus. Brain Res Rev 57:531–553PubMedCrossRef

22.

Barradas MA, Fonseca VA, Gill DS, Jeremy JY, Varghese Z, Balliod R, Moorhead J, Dandona P (1991) Intraplatelet serotonin, beta-thromboglobulin, and histamine concentrations and thromboxane A2 synthesis in renal disease. Am J Clin Pathol 96:504–511PubMed

23.

Beautrais AL, Joyce PR, Mulder RT, Fergusson DM, Deavoll BJ, Nightingale SK (1996) Prevalence and comorbidity of mental disorders in persons making serious suicide attempts: a case-control study. Am J Psychiatry 153:1009–1014PubMed

24.

Belanoff JK, Rothschild AJ, Cassidy F, DeBattista C, Baulieu EE, Schold C, Schatzberg AF (2002) An open label trial of C-1073 (mifepristone) for psychotic major depression. Biol Psychiatry 52:386–392PubMedCrossRef

25.

Bernard S, Gonze D, Cajavec B, Herzel H, Kramer A (2007) Synchronization-induced rhythmicity of circadian oscillators in the suprachiasmatic nucleus. PLoS Comput Biol 3:e68PubMedCrossRef

26.

Birmaher B, Ryan ND, Williamson DE, Brent DA, Kaufman J, Dahl RE, Perel J, Nelson B (1996) Childhood and adolescent depression: a review of the past 10 years. Part I. J Am Acad Child Adolesc Psychiatry 35:1427–1439PubMedCrossRef

27.

Bissette G, Klimek V, Pan J, Stockmeier C, Ordway G (2003) Elevated concentrations of CRF in the locus coeruleus of depressed subjects. Neuropsychopharmacology 28:1328–1335PubMedCrossRef

28.

Boza RA, Milanes FJ, Llorente M, Reisch J, Slater VL, Garrigo L (1988) The DST and suicide among depressed alcoholic patients. Am J Psychiatry 145:266–267PubMed

29.

Brady LS, Whitfield HJ Jr, Fox RJ, Gold PW, Herkenham M (1991) Long-term antidepressant administration alters corticotropin-releasing hormone, tyrosine hydroxylase, and mineralocorticoid receptor gene expression in rat brain. Therapeutic implications. J Clin Invest 87:831–837PubMedCrossRef

30.

Bridges FS, Yip PS, Yang KC (2005) Seasonal changes in suicide in the United States, 1971 to 2000. Percept Mot Skills 100:920–924PubMed

31.

Brouwer JP, Appelhof BC, van Rossum EF, Koper JW, Fliers E, Huyser J, Schene AH, Tijssen JG, Van Dyck R, Lamberts SW, Wiersinga WM, Hoogendijk WJ (2006) Prediction of treatment response by HPA-axis and glucocorticoid receptor polymorphisms in major depression. Psychoneuroendocrinology 31:1154–1163PubMedCrossRef

32.

Brown RP, Stoll PM, Stokes PE, Frances A, Sweeney J, Kocsis JH, Mann JJ (1988) Adrenocortical hyperactivity in depression: effects of agitation, delusions, melancholia, and other illness variables. Psychiatry Res 23:167–178PubMedCrossRef

33.

Brunetti M, Maugeri M, Monti F, Nanni T (2006) Temperature and precipitation variability in Italy in the last two centuries from homogenized instrumental time series. Int J Climatol 26:345–381CrossRef

34.

Brunson KL, Grigoriadis DE, Lorang MT, Baram TZ (2002) Corticotropin-releasing hormone (CRH) downregulates the function of its receptor (CRF1) and induces CRF1 expression in hippocampal and cortical regions of the immature rat brain. Exp Neurol 176:75–86PubMedCrossRef

35.

Buijs RM, Scheer FA, Kreier F, Yi C, Bos N, Goncharuk VD, Kalsbeek A (2006) Organization of circadian functions: interaction with the body. Prog Brain Res 153:341–360PubMedCrossRef

36.

Carroll BJ, Curtis GC (1976) Neuroendocrine identification of depressed patients. Aust N Z J Psychiatry 10:13–20PubMedCrossRef

37.

Carroll BJ, Greden JF, Feinberg M (1980) Suicide, neuroendocrine dysfunction and CSF 5-HIAA concentrations in depression. In: Angrist M (ed) Recent advances in neuropsychopharmacology. Pergoman Press, Oxford, pp 307–313

38.

Caspi A, Sugden K, Moffitt TE, Taylor A, Craig IW, Harrington H, McClay J, Mill J, Martin J, Braithwaite A, Poulton R (2003) Influence of life stress on depression: moderation by a polymorphism in the 5-HTT gene. Science 301:386–389PubMedCrossRef

39.

Chalmers DT, Kwak SP, Mansour A, Akil H, Watson SJ (1993) Corticosteroids regulate brain hippocampal 5-HT1A receptor mRNA expression. J Neurosci 13:914–923PubMed

40.

Chrousos GP, Gold PW (1992) The concepts of stress and stress system disorders. Overview of physical and behavioral homeostasis. JAMA 267:1244–1252PubMedCrossRef

41.

Claes SJ (2004) CRH, stress, and major depression: a psychobiological interplay. Vitam Horm 69:117–150PubMedCrossRef

42.

Coccaro EF (1989) Central serotonin and impulsive aggression. Br J Psychiatry 155:52–62

43.

Cortellazzo S, Viero P, Buczko W, Barbui T, de Gaetano G (1985) Platelet 5-hydroxytryptamine transport and storage in myeloproliferative disorders. Scand J Haematol 34:146–151PubMedCrossRef

44.

Coryell WH (2006) Clinical assessment of suicide risk in depressive disorder. CNS Spectr 11:455–461PubMed

45.

Coryell W, Schlesser MA (1981) Suicide and the dexamethasone suppression test in unipolar depression. Am J Psychiatry 138:1120–1121PubMed

46.

Coryell W, Schlesser M (2001) The dexamethasone suppression test and suicide prediction. Am J Psychiatry 158:748–753PubMedCrossRef

47.

Coryell W, Schlesser M (2007) Combined biological tests for suicide prediction. Psychiatry Res 150:187–191PubMedCrossRef

48.

Coryell W, Young E, Carroll B (2006) Hyperactivity of the hypothalamic-pituitary-adrenal axis and mortality in major depressive disorder. Psychiatry Res 142:99–104PubMedCrossRef

49.

Coryell W, Fiedorowicz J, Zimmerman M, Young E (2008) HPA-axis hyperactivity and mortality in psychotic depressive disorder: preliminary findings. Psychoneuroendocrinology 33:654–658PubMedCrossRef

50.

Coste SC, Kesterson RA, Heldwein KA, Stevens SL, Heard AD, Hollis JH, Murray SE, Hill JK, Pantely GA, Hohimer AR, Hatton DC, Phillips TJ, Finn DA, Low MJ, Rittenberg MB, Stenzel P, Stenzel-Poore MP (2000) Abnormal adaptations to stress and impaired cardiovascular function in mice lacking corticotropin-releasing hormone receptor-2. Nat Genet 24:403–409PubMedCrossRef

51.

Currier D, Mann JJ (2008) Stress, genes and the biology of suicidal behavior. Psychiatr Clin North Am 31:247–269PubMedCrossRef

52.

Dai J, Swaab DF, Buijs RM (1997) Distribution of vasopressin and vasoactive intestinal polypeptide (VIP) fibers in the human hypothalamus with special emphasis on suprachiasmatic nucleus efferent projections. J Comp Neurol 383:397–414PubMedCrossRef

53.

Dai J, Swaab DF, Van der Vliet J, Buijs RM (1998) Postmortem tracing reveals the organization of hypothalamic projections of the suprachiasmatic nucleus in the human brain. J Comp Neurol 400:87–102PubMedCrossRef

54.

Dai J, Van der Vliet J, Swaab DF, Buijs RM (1998) Human retinohypothalamic tract as revealed by in vitro postmortem tracing. J Comp Neurol 397:357–370PubMedCrossRef

55.

de Kloet ER, Joels M, Holsboer F (2005) Stress and the brain: from adaptation to disease. Nat Rev Neurosci 6:463–475PubMedCrossRef

56.

De Luca V, Tharmalingam S, Kennedy JL (2007) Association study between the corticotropin-releasing hormone receptor 2 gene and suicidality in bipolar disorder. Eur Psychiatry 22:282–287PubMedCrossRef

57.

Deisenhammer EA (2003) Weather and suicide: the present state of knowledge on the association of meteorological factors with suicidal behaviour. Acta Psychiatr Scand 108:402–409PubMedCrossRef

58.

Dening TR (2004) Lithium and motor vehicle crashes: perhaps bipolar disorder is the risk, not its treatment. BMJ 328:895–896 author reply 896PubMedCrossRef

59.

Deshauer D, Grof E, Alda M, Grof P (1999) Patterns of DST positivity in remitted affective disorders. Biol Psychiatry 45:1023–1029PubMedCrossRef

60.

Diorio D, Viau V, Meaney MJ (1993) The role of the medial prefrontal cortex (cingulate gyrus) in the regulation of hypothalamic-pituitary-adrenal responses to stress. J Neurosci 13:3839–3847PubMed

61.

Dorn LD, Burgess ES, Dubbert B, Simpson SE, Friedman T, Kling M, Gold PW, Chrousos GP (1995) Psychopathology in patients with endogenous Cushing’s syndrome: ‘atypical’ or melancholic features. Clin Endocrinol 43:433–442CrossRef

62.

Drevets WC, Thase ME, Moses-Kolko EL, Price J, Frank E, Kupfer DJ, Mathis C (2007) Serotonin-1A receptor imaging in recurrent depression: replication and literature review. Nucl Med Biol 34:865–877PubMedCrossRef

63.

Durkheim E (1897) Le suicide. Felix Alcan, Paris

64.

Ehnvall A, Sjogren M, Zachrisson OC, Agren H (2004) HPA axis activation determined by the CRH challenge test in patients with few versus multiple episodes of treatment-refractory depression. Eur Arch Psychiatry Clin Neurosci 254:349–355PubMedCrossRef

65.

Emslie GJ, Mayes TL, Laptook RS, Batt M (2003) Predictors of response to treatment in children and adolescents with mood disorders. Psychiatr Clin North Am 26:435–456PubMedCrossRef

66.

Evans S, Newton R, Higgins S (2005) Nutritional intervention to prevent weight gain in patients commenced on olanzapine: a randomized controlled trial. Aust N Z J Psychiatry 39:479–486PubMed

67.

Fawcett J, Busch KA, Jacobs D, Kravitz HM, Fogg L (1997) Suicide: a four-pathway clinical-biochemical model. Ann N Y Acad Sci 836:288–301PubMedCrossRef

68.

Fountoulakis KN, Gonda X, Rihmer Z, Fokas C, Iacovides A (2008) Revisiting the Dexamethasone Suppression Test in unipolar major depression: an exploratory study. Ann Gen Psychiatry 7:22PubMedCrossRef

69.

Freitas GV, Cais CF, Stefanello S, Botega NJ (2008) Psychosocial conditions and suicidal behavior in pregnant teenagers : a case-control study in Brazil. Eur Child Adolesc Psychiatry 17:336–342PubMedCrossRef

70.

Fuchs E, Czeh B, Kole MH, Michaelis T, Lucassen PJ (2004) Alterations of neuroplasticity in depression: the hippocampus and beyond. Eur Neuropsychopharmacol 14(Suppl 5):S481–S490PubMedCrossRef

71.

Furgal-Borzych A, Lis GJ, Litwin JA, Rzepecka-Wozniak E, Trela F, Cichocki T (2007) Increased incidence of pituitary microadenomas in suicide victims. Neuropsychobiology 55:163–166PubMedCrossRef

72.

Garland MR, Hallahan B, McNamara M, Carney PA, Grimes H, Hibbeln JR, Harkin A, Conroy RM (2007) Lipids and essential fatty acids in patients presenting with self-harm. Br J Psychiatry 190:112–117PubMedCrossRef

73.

Garner B, Pariante CM, Wood SJ, Velakoulis D, Phillips L, Soulsby B, Brewer WJ, Smith DJ, Dazzan P, Berger GE, Yung AR, van den Buuse M, Murray R, McGorry PD, Pantelis C (2005) Pituitary volume predicts future transition to psychosis in individuals at ultra-high risk of developing psychosis. Biol Psychiatry 58:417–423PubMedCrossRef

74.

Gass P, Kretz O, Wolfer DP, Berger S, Tronche F, Reichardt HM, Kellendonk C, Lipp HP, Schmid W, Schutz G (2000) Genetic disruption of mineralocorticoid receptor leads to impaired neurogenesis and granule cell degeneration in the hippocampus of adult mice. EMBO Rep 1:447–451PubMedCrossRef

75.

Gertz BJ, Contreras LN, McComb DJ, Kovacs K, Tyrrell JB, Dallman MF (1987) Chronic administration of corticotropin-releasing factor increases pituitary corticotroph number. Endocrinology 120:381–388PubMedCrossRef

76.

Gold PW, Chrousos GP (2002) Organization of the stress system and its dysregulation in melancholic and atypical depression: high vs low CRH/NE states. Mol Psychiatry 7:254–275PubMedCrossRef

77.

Gold PW, Licinio J, Wong ML, Chrousos GP (1995) Corticotropin releasing hormone in the pathophysiology of melancholic and atypical depression and in the mechanism of action of antidepressant drugs. Ann N Y Acad Sci 771:716–729PubMedCrossRef

78.

Golden RN, Gilmore JH, Corrigan MH, Ekstrom RD, Knight BT, Garbutt JC (1991) Serotonin, suicide, and aggression: clinical studies. J Clin Psychiatry 52(Suppl):61–69PubMed

79.

Goldstein RB, Black DW, Nasrallah A, Winokur G (1991) The prediction of suicide. Sensitivity, specificity, predictive value of a multivariate model applied to suicide among 1906 patients with affective disorders. Arch Gen Psychiatry 48:418–422PubMed

80.

Golomb BA (1998) Cholesterol and violence: is there a connection? Ann Intern Med 128:478–487PubMed

81.

Goodwin FK, Jamison KR (2007) Manic-depressive illness. Oxford University Press, New York

82.

Goodyer IM, Herbert J, Tamplin A, Altham PM (2000) Recent life events, cortisol, dehydroepiandrosterone and the onset of major depression in high-risk adolescents. Br J Psychiatry 177:499–504PubMedCrossRef

83.

Grino M, Guillaume V, Castanas E, Boudouresque F, Conte-Devolx B, Oliver C (1987) Effect of passive immunization against corticotropin-releasing factor (CRF) on the postadrenalectomy changes of CRF binding sites in the rat anterior pituitary gland. Neuroendocrinology 45:492–497PubMedCrossRef

84.

Guicheney P, Baudouin-Legros M, Meyer P (1987) In vivo platelet activation in mild arterial hypertension. Arch Mal Coeur Vaiss 80:808–811PubMed

85.

Hajat S, Kovats RS, Atkinson RW, Haines A (2002) Impact of hot temperatures on death in London: a time series approach. J Epidemiol Community Health 56:367–372PubMedCrossRef

86.

Harris TO, Borsanyi S, Messari S, Stanford K, Cleary SE, Shiers HM, Brown GW, Herbert J (2000) Morning cortisol as a risk factor for subsequent major depressive disorder in adult women. Br J Psychiatry 177:505–510PubMedCrossRef

87.

Hauger RL, Risbrough V, Brauns O, Dautzenberg FM (2006) Corticotropin releasing factor (CRF) receptor signaling in the central nervous system: new molecular targets. CNS Neurol Disord Drug Targets 5:453–479PubMedCrossRef

88.

Heim C, Nemeroff CB (2001) The role of childhood trauma in the neurobiology of mood and anxiety disorders: preclinical and clinical studies. Biol Psychiatry 49:1023–1039PubMedCrossRef

89.

Heim C, Ehlert U, Hellhammer DH (2000) The potential role of hypocortisolism in the pathophysiology of stress-related bodily disorders. Psychoneuroendocrinology 25:1–35PubMedCrossRef

90.

Herman JP, Schafer MK, Young EA, Thompson R, Douglass J, Akil H, Watson SJ (1989) Evidence for hippocampal regulation of neuroendocrine neurons of the hypothalamo-pituitary-adrenocortical axis. J Neurosci 9:3072–3082PubMed

91.

Heuser IJ, Gotthardt U, Schweiger U, Schmider J, Lammers CH, Dettling M, Holsboer F (1994) Age-associated changes of pituitary-adrenocortical hormone regulation in humans: importance of gender. Neurobiol Aging 15:227–231PubMedCrossRef

92.

Heuser I, Bissette G, Dettling M, Schweiger U, Gotthardt U, Schmider J, Lammers CH, Nemeroff CB, Holsboer F (1998) Cerebrospinal fluid concentrations of corticotropin-releasing hormone, vasopressin, and somatostatin in depressed patients and healthy controls: response to amitriptyline treatment. Depress Anxiety 8:71–79PubMedCrossRef

93.

Holsboer F (2000) The corticosteroid receptor hypothesis of depression. Neuropsychopharmacology 23:477–501PubMedCrossRef

94.

Holsboer F (2001) Stress, hypercortisolism and corticosteroid receptors in depression: implications for therapy. J Affect Disord 62:77–91PubMedCrossRef

95.

Holsboer F, von Bardeleben U, Wiedemann K, Muller OA, Stalla GK (1987) Serial assessment of corticotropin-releasing hormone response after dexamethasone in depression. Implications for pathophysiology of DST nonsuppression. Biol Psychiatry 22:228–234PubMedCrossRef

96.

Holsboer F, Lauer CJ, Schreiber W, Krieg JC (1995) Altered hypothalamic-pituitary-adrenocortical regulation in healthy subjects at high familial risk for affective disorders. Neuroendocrinology 62:340–347PubMedCrossRef

97.

Hucks D, Lowther S, Crompton MR, Katona CL, Horton RW (1997) Corticotropin-releasing factor binding sites in cortex of depressed suicides. Psychopharmacology (Berl) 134:174–178CrossRef

98.

Ising M, Horstmann S, Kloiber S, Lucae S, Binder EB, Kern N, Kunzel HE, Pfennig A, Uhr M, Holsboer F (2007) Combined dexamethasone/corticotropin releasing hormone test predicts treatment response in major depression—a potential biomarker? Biol Psychiatry 62:47–54PubMedCrossRef

99.

Jessen G, Steffensen P, Jensen B (1998) Seasons and meteorological factors in suicidal behaviour: findings and methodological considerations from a Danish study. Arch Suicide Res 4:263–280

100.

Jokinen J, Nordstrom P (2008) HPA axis hyperactivity as suicide predictor in elderly mood disorder inpatients. Psychoneuroendocrinology 33:1387–1393PubMedCrossRef

101.

Jokinen J, Nordstrom P (2009) HPA axis hyperactivity and attempted suicide in young adult mood disorder inpatients. J Affect Disord 116:117–120PubMedCrossRef

102.

Jokinen J, Carlborg A, Martensson B, Forslund K, Nordstrom AL, Nordstrom P (2007) DST non-suppression predicts suicide after attempted suicide. Psychiatry Res 150:297–303PubMedCrossRef

103.

Jokinen J, Martensson B, Nordstrom AL, Nordstrom P (2008) CSF 5-HIAA and DST non-suppression-independent biomarkers in suicide attempters? J Affect Disord 105:241–245PubMedCrossRef

104.

Jokinen J, Nordstrom AL, Nordstrom P (2008) ROC analysis of dexamethasone suppression test threshold in suicide prediction after attempted suicide. J Affect Disord 106:145–152PubMedCrossRef

105.

Jokinen J, Nordstrom AL, Nordstrom P (2009) CSF 5-HIAA and DST non-suppression—orthogonal biologic risk factors for suicide in male mood disorder inpatients. Psychiatry Res 165:96–102PubMedCrossRef

106.

Jovev M, Garner B, Phillips L, Velakoulis D, Wood SJ, Jackson HJ, Pantelis C, McGorry PD, Chanen AM (2008) An MRI study of pituitary volume and parasuicidal behavior in teenagers with first-presentation borderline personality disorder. Psychiatry Res 162:273–277PubMedCrossRef

107.

Kathol RG (1985) Persistent elevation of urinary free cortisol and loss of circannual periodicity in recovered depressive patients. A trait finding. J Affect Disord 8:137–145PubMedCrossRef

108.

Keck ME, Holsboer F (2001) Hyperactivity of CRH neuronal circuits as a target for therapeutic interventions in affective disorders. Peptides 22:835–844PubMedCrossRef

109.

Kendler KS, Karkowski LM, Prescott CA (1999) Causal relationship between stressful life events and the onset of major depression. Am J Psychiatry 156:837–841PubMed

110.

Kevan SM (1980) Perspectives on season of suicide: a review. Soc Sci Med [Med Geogr] 14:369–378

111.

Kim JJ, Diamond DM (2002) The stressed hippocampus, synaptic plasticity and lost memories. Nat Rev Neurosci 3:453–462PubMedCrossRef

112.

Krishnan KR, Doraiswamy PM, Lurie SN, Figiel GS, Husain MM, Boyko OB, Ellinwood EH Jr, Nemeroff CB (1991) Pituitary size in depression. J Clin Endocrinol Metab 72:256–259PubMedCrossRef

113.

Ladd CO, Huot RL, Thrivikraman KV, Nemeroff CB, Plotsky PM (2004) Long-term adaptations in glucocorticoid receptor and mineralocorticoid receptor mRNA and negative feedback on the hypothalamo-pituitary-adrenal axis following neonatal maternal separation. Biol Psychiatry 55:367–375PubMedCrossRef

114.

Lamolet B, Pulichino AM, Lamonerie T, Gauthier Y, Brue T, Enjalbert A, Drouin J (2001) A pituitary cell-restricted T box factor, Tpit, activates POMC transcription in cooperation with Pitx homeoproteins. Cell 104:849–859PubMedCrossRef

115.

Landfield PW, Blalock EM, Chen KC, Porter NM (2007) A new glucocorticoid hypothesis of brain aging: implications for Alzheimer’s disease. Curr Alzheimer Res 4:205–212PubMedCrossRef

116.

Lee HC, Lin HC, Tsai SY, Li CY, Chen CC, Huang CC (2006) Suicide rates and the association with climate: a population-based study. J Affect Disord 92:221–226PubMedCrossRef

117.

Lester D (1983) Monthly variation of suicidal and accidental poisoning deaths. Br J Psychiatry 143:204–205PubMedCrossRef

118.

Lester D (1988) Geophysical variables and behavior: XLVIII. Climate and personal violence (suicide and homicide): a cross-cultural study. Percept Mot Skills 66:602PubMed

119.

Lester D (1992) The dexamethasone suppression test as an indicator of suicide: a meta-analysis. Pharmacopsychiatry 25:265–270PubMedCrossRef

120.

Lester D (1995) The concentration of neurotransmitter metabolites in the cerebrospinal fluid of suicidal individuals: a meta-analysis. Pharmacopsychiatry 28:45–50PubMedCrossRef

121.

Liaw CW, Lovenberg TW, Barry G, Oltersdorf T, Grigoriadis DE, de Souza EB (1996) Cloning and characterization of the human corticotropin-releasing factor-2 receptor complementary deoxyribonucleic acid. Endocrinology 137:72–77PubMedCrossRef

122.

Lindqvist D, Isaksson A, Traskman-Bendz L, Brundin L (2008) Salivary cortisol and suicidal behavior—a follow-up study. Psychoneuroendocrinology 33:1061–1068PubMedCrossRef

123.

Liu J, Lin C, Gleiberman A, Ohgi KA, Herman T, Huang HP, Tsai MJ, Rosenfeld MG (2001) Tbx19, a tissue-selective regulator of POMC gene expression. Proc Natl Acad Sci USA 98:8674–8679PubMedCrossRef

124.

Liu Z, Zhu F, Wang G, Xiao Z, Wang H, Tang J, Wang X, Qiu D, Liu W, Cao Z, Li W (2006) Association of corticotropin-releasing hormone receptor1 gene SNP and haplotype with major depression. Neurosci Lett 404:358–362PubMedCrossRef

125.

Lolait SJ, Stewart LQ, Jessop DS, Young WS III, O’Carroll AM (2007) The hypothalamic-pituitary-adrenal axis response to stress in mice lacking functional vasopressin V1b receptors. Endocrinology 148:849–856PubMedCrossRef

126.

Lopez JF, Palkovits M, Arato M, Mansour A, Akil H, Watson SJ (1992) Localization and quantification of pro-opiomelanocortin mRNA and glucocorticoid receptor mRNA in pituitaries of suicide victims. Neuroendocrinology 56:491–501PubMedCrossRef

127.

Lopez JF, Chalmers DT, Little KY, Watson SJ (1998) A.E. Bennett Research Award. Regulation of serotonin1A, glucocorticoid, and mineralocorticoid receptor in rat and human hippocampus: implications for the neurobiology of depression. Biol Psychiatry 43:547–573PubMedCrossRef

128.

Lopez-Ibor JJ Jr, Saiz-Ruiz J, Perez de los Cobos JC (1985) Biological correlations of suicide and aggressivity in major depressions (with melancholia): 5-hydroxyindoleacetic acid and cortisol in cerebral spinal fluid, dexamethasone suppression test and therapeutic response to 5-hydroxytryptophan. Neuropsychobiology 14:67–74PubMedCrossRef

129.

Lupien SJ, McEwen BS (1997) The acute effects of corticosteroids on cognition: integration of animal and human model studies. Brain Res Brain Res Rev 24:1–27PubMedCrossRef

130.

Macfarlane A (1978) Daily mortality and environment in English conurbations. II. Deaths during summer hot spells in greater London. Environ Res 15:332–341PubMedCrossRef

131.

MacMaster FP, Russell A, Mirza Y, Keshavan MS, Banerjee SP, Bhandari R, Boyd C, Lynch M, Rose M, Ivey J, Moore GJ, Rosenberg DR (2006) Pituitary volume in pediatric obsessive-compulsive disorder. Biol Psychiatry 59:252–257PubMedCrossRef

132.

Maes M, Meltzer HY, Suy E, De Meyer F (1993) Seasonality in severity of depression: relationships to suicide and homicide occurrence. Acta Psychiatr Scand 88:156–161PubMedCrossRef

133.

Maes M, Scharpe S, Verkerk R, D’Hondt P, Peeters D, Cosyns P, Thompson P, De Meyer F, Wauters A, Neels H (1995) Seasonal variation in plasma l-tryptophan availability in healthy volunteers. Relationships to violent suicide occurrence. Arch Gen Psychiatry 52:937–946PubMed

134.

Maes M, Lin A, Bonaccorso S, van Hunsel F, Van Gastel A, Delmeire L, Biondi M, Bosmans E, Kenis G, Scharpe S (1998) Increased 24-hour urinary cortisol excretion in patients with post-traumatic stress disorder and patients with major depression, but not in patients with fibromyalgia. Acta Psychiatr Scand 98:328–335PubMedCrossRef

135.

Maira M, Couture C, Le Martelot G, Pulichino AM, Bilodeau S, Drouin J (2003) The T-box factor Tpit recruits SRC/p160 co-activators and mediates hormone action. J Biol Chem 278:46523–46532PubMedCrossRef

136.

Malhotra S, Das PP (2007) Understanding childhood depression. Indian J Med Res 125:115–128PubMed

137.

Malison RT, Price LH, Berman R, van Dyck CH, Pelton GH, Carpenter L, Sanacora G, Owens MJ, Nemeroff CB, Rajeevan N, Baldwin RM, Seibyl JP, Innis RB, Charney DS (1998) Reduced brain serotonin transporter availability in major depression as measured by [123I]-2 beta-carbomethoxy-3 beta-(4-iodophenyl)tropane and single photon emission computed tomography. Biol Psychiatry 44:1090–1098PubMedCrossRef

138.

Mann JJ (2003) Neurobiology of suicidal behaviour. Nat Rev Neurosci 4:819–828PubMedCrossRef

139.

Mann JJ, Currier D (2007) A review of prospective studies of biologic predictors of suicidal behavior in mood disorders. Arch Suicide Res 11:3–16PubMedCrossRef

140.

Mann JJ, Waternaux C, Haas GL, Malone KM (1999) Toward a clinical model of suicidal behavior in psychiatric patients. Am J Psychiatry 156:181–189PubMed

141.

Mann JJ, Brent DA, Arango V (2001) The neurobiology and genetics of suicide and attempted suicide: a focus on the serotonergic system. Neuropsychopharmacology 24:467–477PubMedCrossRef

142.

Mann JJ, Currier D, Stanley B, Oquendo MA, Amsel LV, Ellis SP (2006) Can biological tests assist prediction of suicide in mood disorders? Int J Neuropsychopharmacol 9:465–474PubMedCrossRef

143.

Massing W, Angermeyer MC (1985) The monthly and weekly distribution of suicide. Soc Sci Med 21:433–441PubMedCrossRef

144.

McCullers DL, Herman JP (1998) Mineralocorticoid receptors regulate bcl-2 and p53 mRNA expression in hippocampus. Neuroreport 9:3085–3089PubMedCrossRef

145.

McKay MS, Zakzanis KK (2010) The impact of treatment on HPA axis activity in unipolar major depression. J Psychiatr Res 44(3):183–192

146.

McMichael AJ, Woodruff RE, Hales S (2006) Climate change and human health: present and future risks. Lancet 367:859–869PubMedCrossRef

147.

Meijer OC, de Kloet ER (1998) Corticosterone and serotonergic neurotransmission in the hippocampus: functional implications of central corticosteroid receptor diversity. Crit Rev Neurobiol 12:1–20PubMed

148.

Meijer OC, Williamson A, Dallman MF, Pearce D (2000) Transcriptional repression of the 5-HT1A receptor promoter by corticosterone via mineralocorticoid receptors depends on the cellular context. J Neuroendocrinol 12:245–254PubMedCrossRef

149.

Meltzer H (1989) Serotonergic dysfunction in depression. Br J Psychiatry Suppl (8):25–31

150.

Merali Z, Du L, Hrdina P, Palkovits M, Faludi G, Poulter MO, Anisman H (2004) Dysregulation in the suicide brain: mRNA expression of corticotropin-releasing hormone receptors and GABA(A) receptor subunits in frontal cortical brain region. J Neurosci 24:1478–1485PubMedCrossRef

151.

Mergl R, Havers I, Althaus D, Rihmer Z, Schmidtke A, Lehfeld H, Niklewski G, Hegerl U (2009) Seasonality of suicide attempts: association with gender. Eur Arch Psychiatry Clin Neurosci. doi:10.1007/s00406-009-0086-1

152.

Micciolo R, Zimmermann-Tansella C, Williams P, Tansella M (1989) Seasonal variation in suicide: is there a sex difference? Psychol Med 19:199–203PubMedCrossRef

153.

Mitchell AJ (1998) The role of corticotropin releasing factor in depressive illness: a critical review. Neurosci Biobehav Rev 22:635–651PubMedCrossRef

154.

Mitchell A, O’Keane V (1998) Steroids and depression. BMJ 316:244–245PubMed

155.

Mizoguchi K, Ishige A, Aburada M, Tabira T (2003) Chronic stress attenuates glucocorticoid negative feedback: involvement of the prefrontal cortex and hippocampus. Neuroscience 119:887–897PubMedCrossRef

156.

Modell S, Yassouridis A, Huber J, Holsboer F (1997) Corticosteroid receptor function is decreased in depressed patients. Neuroendocrinology 65:216–222PubMedCrossRef

157.

Morselli E (1881) Suicide. An essay on comparative moral statistic. C. Kegan Paul & C, London

158.

Morsink MC, Steenbergen PJ, Vos JB, Karst H, Joels M, De Kloet ER, Datson NA (2006) Acute activation of hippocampal glucocorticoid receptors results in different waves of gene expression throughout time. J Neuroendocrinol 18:239–252PubMedCrossRef

159.

Muldoon MF, Kaplan JR, Manuck SB, Mann JJ (1992) Effects of a low-fat diet on brain serotonergic responsivity in cynomolgus monkeys. Biol Psychiatry 31:739–742PubMedCrossRef

160.

Murphy BE (1997) Antiglucocorticoid therapies in major depression: a review. Psychoneuroendocrinology 22(Suppl 1):S125–S132PubMed

161.

Murphy GM Jr, Hollander SB, Rodrigues HE, Kremer C, Schatzberg AF (2004) Effects of the serotonin transporter gene promoter polymorphism on mirtazapine and paroxetine efficacy and adverse events in geriatric major depression. Arch Gen Psychiatry 61:1163–1169PubMedCrossRef

162.

Nakaji S, Parodi S, Fontana V, Umeda T, Suzuki K, Sakamoto J, Fukuda S, Wada S, Sugawara K (2004) Seasonal changes in mortality rates from main causes of death in Japan (1970–1999). Eur J Epidemiol 19:905–913PubMedCrossRef

163.

Nayha S (1982) Autumn incidence of suicides re-examined: data from Finland by sex, age and occupation. Br J Psychiatry 141:512–517PubMedCrossRef

164.

Nayha S (1983) The bi-seasonal incidence of some suicides. Experience from Finland by marital status, 1961–1976. Acta Psychiatr Scand 67:32–42PubMedCrossRef

165.

Nemeroff CB (1996) The corticotropin-releasing factor (CRF) hypothesis of depression: new findings and new directions. Mol Psychiatry 1:336–342PubMed

166.

Nemeroff CB, Owens MJ, Bissette G, Andorn AC, Stanley M (1988) Reduced corticotropin releasing factor binding sites in the frontal cortex of suicide victims. Arch Gen Psychiatry 45:577–579PubMed

167.

Nielsen J, Bostwick JM (2004) The dexamethasone suppression test as a predictor of suicide risk. Academy of Psychosomatic Medicine: proceedings from the 50th annual meeting 20–23 Nov 2003, Coronado (San Diego), California. Psychosomatics 45:2, 157

168.

Norman WH, Brown WA, Miller IW, Keitner GI, Overholser JC (1990) The dexamethasone suppression test and completed suicide. Acta Psychiatr Scand 81:120–125PubMedCrossRef

169.

O’Brien JT, Ames D, Schweitzer I, Colman P, Desmond P, Tress B (1996) Clinical and magnetic resonance imaging correlates of hypothalamic-pituitary-adrenal axis function in depression and Alzheimer’s disease. Br J Psychiatry 168:679–687PubMedCrossRef

170.

O’Brien D, Skelton KH, Owens MJ, Nemeroff CB (2001) Are CRF receptor antagonists potential antidepressants? Hum Psychopharmacol 16:81–87PubMedCrossRef

171.

Oldehinkel AJ, van den Berg MD, Flentge F, Bouhuys AL, ter Horst GJ, Ormel J (2001) Urinary free cortisol excretion in elderly persons with minor and major depression. Psychiatry Res 104:39–47PubMedCrossRef

172.

Oquendo MA, Placidi GP, Malone KM, Campbell C, Keilp J, Brodsky B, Kegeles LS, Cooper TB, Parsey RV, van Heertum RL, Mann JJ (2003) Positron emission tomography of regional brain metabolic responses to a serotonergic challenge and lethality of suicide attempts in major depression. Arch Gen Psychiatry 60:14–22PubMedCrossRef

173.

Oquendo MA, Russo SA, Underwood MD, Kassir SA, Ellis SP, Mann JJ, Arango V (2006) Higher postmortem prefrontal 5-HT2A receptor binding correlates with lifetime aggression in suicide. Biol Psychiatry 59:235–243PubMedCrossRef

174.

Oravecz R, Czigler B, Leskosek F (2003) Correlation between suicide rate and antidepressant use in Slovenia. Arch Suicide Res 7:279–285CrossRef

175.

Oravecz R, Rocchi MB, Sisti D, Zorko M, Marusic A, Preti A (2006) Changes in the seasonality of suicides over time in Slovenia, 1971 to 2002. J Affect Disord 95:135–140PubMedCrossRef

176.

Otte C, Hart S, Neylan TC, Marmar CR, Yaffe K, Mohr DC (2005) A meta-analysis of cortisol response to challenge in human aging: importance of gender. Psychoneuroendocrinology 30:80–91PubMedCrossRef

177.

Owens MJ, Nemeroff CB (1991) Physiology and pharmacology of corticotropin-releasing factor. Pharmacol Rev 43:425–473PubMed

178.

Ozalp E (2009) The genetics of suicidal behavior. Turk Psikiyatri Derg 20:85–93PubMed

179.

Pariante CM (2003) Depression, stress and the adrenal axis. J Neuroendocrinol 15:811–812PubMedCrossRef

180.

Pariante CM, Miller AH (2001) Glucocorticoid receptors in major depression: relevance to pathophysiology and treatment. Biol Psychiatry 49:391–404PubMedCrossRef

181.

Pariante CM, Vassilopoulou K, Velakoulis D, Phillips L, Soulsby B, Wood SJ, Brewer W, Smith DJ, Dazzan P, Yung AR, Zervas IM, Christodoulou GN, Murray R, McGorry PD, Pantelis C (2004) Pituitary volume in psychosis. Br J Psychiatry 185:5–10PubMedCrossRef

182.

Parsey RV, Hastings RS, Oquendo MA, Huang YY, Simpson N, Arcement J, Huang Y, Ogden RT, Van Heertum RL, Arango V, Mann JJ (2006) Lower serotonin transporter binding potential in the human brain during major depressive episodes. Am J Psychiatry 163:52–58PubMedCrossRef

183.

Patel PD, Lopez JF, Lyons DM, Burke S, Wallace M, Schatzberg AF (2000) Glucocorticoid and mineralocorticoid receptor mRNA expression in squirrel monkey brain. J Psychiatr Res 34:383–392PubMedCrossRef

184.

Patel PD, Katz M, Karssen AM, Lyons DM (2008) Stress-induced changes in corticosteroid receptor expression in primate hippocampus and prefrontal cortex. Psychoneuroendocrinology 33:360–367PubMedCrossRef

185.

Paykel ES (2001) Stress and affective disorders in humans. Semin Clin Neuropsychiatry 6:4–11PubMedCrossRef

186.

Pfennig A, Kunzel HE, Kern N, Ising M, Majer M, Fuchs B, Ernst G, Holsboer F, Binder EB (2005) Hypothalamus-pituitary-adrenal system regulation and suicidal behavior in depression. Biol Psychiatry 57:336–342PubMedCrossRef

187.

Plotsky PM, Owens MJ, Nemeroff CB (1998) Psychoneuroendocrinology of depression. Hypothalamic-pituitary-adrenal axis. Psychiatr Clin North Am 21:293–307PubMedCrossRef

188.

Pompili M, Ehrlich S, De Pisa E, Mann JJ, Innamorati M, Cittadini A, Montagna B, Iliceto P, Romano A, Amore M, Tatarelli R, Girardi P (2007) White matter hyperintensities and their associations with suicidality in patients with major affective disorders. Eur Arch Psychiatry Clin Neurosci 257:494–499PubMedCrossRef

189.

Porter RJ, Gallagher P, Watson S, Young AH (2004) Corticosteroid-serotonin interactions in depression: a review of the human evidence. Psychopharmacology (Berl) 173:1–17CrossRef

190.

Potter E, Behan DP, Fischer WH, Linton EA, Lowry PJ, Vale WW (1991) Cloning and characterization of the cDNAs for human and rat corticotropin releasing factor-binding proteins. Nature 349:423–426PubMedCrossRef

191.

Praschak-Rieder N, Willeit M, Wilson AA, Houle S, Meyer JH (2008) Seasonal variation in human brain serotonin transporter binding. Arch Gen Psychiatry 65:1072–1078PubMedCrossRef

192.

Preti A (1997) The influence of seasonal change on suicidal behaviour in Italy. J Affect Disord 44:123–130PubMedCrossRef

193.

Preti A, Lentini G, Maugeri M (2007) Global warming possibly linked to an enhanced risk of suicide: data from Italy, 1974–2003. J Affect Disord 102:19–25PubMedCrossRef

194.

Pryce CR, Feldon J, Fuchs E, Knuesel I, Oertle T, Sengstag C, Spengler M, Weber E, Weston A, Jongen-Relo A (2005) Postnatal ontogeny of hippocampal expression of the mineralocorticoid and glucocorticoid receptors in the common marmoset monkey. Eur J Neurosci 21:1521–1535PubMedCrossRef

195.

Quirarte GL, Roozendaal B, McGaugh JL (1997) Glucocorticoid enhancement of memory storage involves noradrenergic activation in the basolateral amygdala. Proc Natl Acad Sci USA 94:14048–14053PubMedCrossRef

196.

Raadsheer FC, Hoogendijk WJ, Stam FC, Tilders FJ, Swaab DF (1994) Increased numbers of corticotropin-releasing hormone expressing neurons in the hypothalamic paraventricular nucleus of depressed patients. Neuroendocrinology 60:436–444PubMedCrossRef

197.

Raadsheer FC, van Heerikhuize JJ, Lucassen PJ, Hoogendijk WJ, Tilders FJ, Swaab DF (1995) Corticotropin-releasing hormone mRNA levels in the paraventricular nucleus of patients with Alzheimer’s disease and depression. Am J Psychiatry 152:1372–1376PubMed

198.

Rao VP, Krishnan KR, Goli V, Saunders WB, Ellinwood EH Jr, Blazer DG, Nemeroff CB (1989) Neuroanatomical changes and hypothalamo-pituitary-adrenal axis abnormalities. Biol Psychiatry 26:729–732PubMedCrossRef

199.

Rene P, Lenne F, Ventura MA, Bertagna X, de Keyzer Y (2000) Nucleotide sequence and structural organization of the human vasopressin pituitary receptor (V3) gene. Gene 241:57–64PubMedCrossRef

200.

Reppert SM, Weaver DR (2002) Coordination of circadian timing in mammals. Nature 418:935–941PubMedCrossRef

201.

Reus VI, Wolkowitz OM, Frederick S (1997) Antiglucocorticoid treatments in psychiatry. Psychoneuroendocrinology 22(Suppl 1):S121–S124PubMedCrossRef

202.

Reutfors J, Osby U, Ekbom A, Nordstrom P, Jokinen J, Papadopoulos FC (2009) Seasonality of suicide in Sweden: relationship with psychiatric disorder. J Affect Disord 119:59–65PubMedCrossRef

203.

Ribeiro SC, Tandon R, Grunhaus L, Greden JF (1993) The DST as a predictor of outcome in depression: a meta-analysis. Am J Psychiatry 150:1618–1629PubMed

204.

Rihmer Z (1987) The geography of DST. Biol Psychiatry 22:1044–1045PubMedCrossRef

205.

Rihmer Z, Rutz W, Pihlgren H, Pestality P (1998) Decreasing tendency of seasonality in suicide may indicate lowering rate of depressive suicides in the population. Psychiatry Res 81:233–240PubMedCrossRef

206.

Rocchi MB, Sisti D, Cascio MT, Preti A (2007) Seasonality and suicide in Italy: amplitude is positively related to suicide rates. J Affect Disord 100:129–136PubMedCrossRef

207.

Rock D, Greenberg DM, Hallmayer JF (2003) Increasing seasonality of suicide in Australia 1970–1999. Psychiatry Res 120:43–51PubMedCrossRef

208.

Roozendaal B (2002) Stress and memory: opposing effects of glucocorticoids on memory consolidation and memory retrieval. Neurobiol Learn Mem 78:578–595PubMedCrossRef

209.

Rosenthal NE, Lewy AJ, Wehr TA, Kern HE, Goodwin FK (1983) Seasonal cycling in a bipolar patient. Psychiatry Res 8:25–31PubMedCrossRef

210.

Roy A (1992) Hypothalamic-pituitary-adrenal axis function and suicidal behavior in depression. Biol Psychiatry 32:812–816PubMedCrossRef

211.

Roy A, Jimerson DC, Pickar D (1986) Plasma MHPG in depressive disorders and relationship to the dexamethasone suppression test. Am J Psychiatry 143:846–851PubMed

212.

Roy A, Lamparski D, De Jong J, Adinoff B, Ravitz B, George DT, Nutt D, Linnoila M (1990) Cerebrospinal fluid monoamine metabolites in alcoholic patients who attempt suicide. Acta Psychiatr Scand 81:58–61PubMedCrossRef

213.

Rozeboom AM, Akil H, Seasholtz AF (2007) Mineralocorticoid receptor overexpression in forebrain decreases anxiety-like behavior and alters the stress response in mice. Proc Natl Acad Sci USA 104:4688–4693PubMedCrossRef

214.

Rubin RT, Phillips JJ, McCracken JT, Sadow TF (1996) Adrenal gland volume in major depression: relationship to basal and stimulated pituitary-adrenal cortical axis function. Biol Psychiatry 40:89–97PubMedCrossRef

215.

Rybakowski JK, Twardowska K (1999) The dexamethasone/corticotropin-releasing hormone test in depression in bipolar and unipolar affective illness. J Psychiatr Res 33:363–370PubMedCrossRef

216.

Sanchez MM, Young LJ, Plotsky PM, Insel TR (2000) Distribution of corticosteroid receptors in the rhesus brain: relative absence of glucocorticoid receptors in the hippocampal formation. J Neurosci 20:4657–4668PubMed

217.

Sassi RB, Nicoletti M, Brambilla P, Harenski K, Mallinger AG, Frank E, Kupfer DJ, Keshavan MS, Soares JC (2001) Decreased pituitary volume in patients with bipolar disorder. Biol Psychiatry 50:271–280PubMedCrossRef

218.

Schar C, Vidale PL, Luthi D, Frei C, Haberli C, Liniger MA, Appenzeller C (2004) The role of increasing temperature variability in European summer heatwaves. Nature 427:332–336PubMedCrossRef

219.

Schule C, Baghai T, Zwanzger P, Ella R, Eser D, Padberg F, Moller HJ, Rupprecht R (2003) Attenuation of hypothalamic-pituitary-adrenocortical hyperactivity in depressed patients by mirtazapine. Psychopharmacology (Berl) 166:271–275

220.

Schule C, Baghai TC, Eser D, Zwanzger P, Jordan M, Buechs R, Rupprecht R (2006) Time course of hypothalamic-pituitary-adrenocortical axis activity during treatment with reboxetine and mirtazapine in depressed patients. Psychopharmacology (Berl) 186:601–611CrossRef

221.

Schule C, Baghai TC, Eser D, Hafner S, Born C, Herrmann S, Rupprecht R (2009) The combined dexamethasone/CRH Test (DEX/CRH test) and prediction of acute treatment response in major depression. PLoS One 4:e4324PubMedCrossRef

222.

Scott LV, Dinan TG (1998) Vasopressin and the regulation of hypothalamic-pituitary-adrenal axis function: implications for the pathophysiology of depression. Life Sci 62:1985–1998PubMedCrossRef

223.

Secunda SK, Cross CK, Koslow S, Katz MM, Kocsis J, Maas JW, Landis H (1986) Biochemistry and suicidal behavior in depressed patients. Biol Psychiatry 21:756–767PubMedCrossRef

224.

Shaffer D, Gould MS, Fisher P, Trautman P, Moreau D, Kleinman M, Flory M (1996) Psychiatric diagnosis in child and adolescent suicide. Arch Gen Psychiatry 53:339–348PubMed

225.

Shah PJ, Ebmeier KP, Glabus MF, Goodwin GM (1998) Cortical grey matter reductions associated with treatment-resistant chronic unipolar depression. Controlled magnetic resonance imaging study. Br J Psychiatry 172:527–532PubMedCrossRef

226.

Sharma R, Markar HR (1994) Mortality in affective disorder. J Affect Disord 31:91–96PubMedCrossRef

227.

Sher L (2006) Combined dexamethasone suppression-corticotropin-releasing hormone stimulation test in studies of depression, alcoholism, and suicidal behavior. Sci World J 6:1398–1404

228.

Sher L, Cooper TB, Mann JJ, Oquendo MA (2006) Modified dexamethasone suppression-corticotropin-releasing hormone stimulation test: A pilot study of young healthy volunteers and implications for alcoholism research in adolescents and young adults. Int J Adolesc Med Health 18:133–137PubMed

229.

Smith CC, Betteridge DJ (1997) Reduced platelet serotonin content and release in familial hypercholesterolaemia. Atherosclerosis 130:87–92PubMedCrossRef

230.

Smith SM, Vale WW (2006) The role of the hypothalamic-pituitary-adrenal axis in neuroendocrine responses to stress. Dialogues Clin Neurosci 8:383–395PubMed

231.

Smith GW, Aubry JM, Dellu F, Contarino A, Bilezikjian LM, Gold LH, Chen R, Marchuk Y, Hauser C, Bentley CA, Sawchenko PE, Koob GF, Vale W, Lee KF (1998) Corticotropin releasing factor receptor 1-deficient mice display decreased anxiety, impaired stress response, and aberrant neuroendocrine development. Neuron 20:1093–1102PubMedCrossRef

232.

Sousa N, Almeida OF (2002) Corticosteroids: sculptors of the hippocampal formation. Rev Neurosci 13:59–84PubMed

233.

Stanley B, Molcho A, Stanley M, Winchel R, Gameroff MJ, Parsons B, Mann JJ (2000) Association of aggressive behavior with altered serotonergic function in patients who are not suicidal. Am J Psychiatry 157:609–614PubMedCrossRef

234.

Stenzel-Poore MP, Heinrichs SC, Rivest S, Koob GF, Vale WW (1994) Overproduction of corticotropin-releasing factor in transgenic mice: a genetic model of anxiogenic behavior. J Neurosci 14:2579–2584PubMed

235.

Sunnqvist C, Westrin A, Traskman-Bendz L (2008) Suicide attempters: biological stressmarkers and adverse life events. Eur Arch Psychiatry Clin Neurosci 258:456–462PubMedCrossRef

236.

Swaab DF, Bao AM, Lucassen PJ (2005) The stress system in the human brain in depression and neurodegeneration. Ageing Res Rev 4:141–194PubMedCrossRef

237.

Szigethy E, Conwell Y, Forbes NT, Cox C, Caine ED (1994) Adrenal weight and morphology in victims of completed suicide. Biol Psychiatry 36:374–380PubMedCrossRef

238.

Szymanska M, Budziszewska B, Jaworska-Feil L, Basta-Kaim A, Kubera M, Leskiewicz M, Regulska M, Lason W (2009) The effect of antidepressant drugs on the HPA axis activity, glucocorticoid receptor level and FKBP51 concentration in prenatally stressed rats. Psychoneuroendocrinology 34:822–832PubMedCrossRef

239.

Tanney BL (1992) Mental disorders, psychiatric patients and suicide. In: Maris RW, Berman AL, Maltsberger JT, Yufit RI (eds) Assessment and prediction of suicide. Guilford Press, New York, pp 277–320

240.

Targum SD, Rosen L, Capodanno AE (1983) The dexamethasone suppression test in suicidal patients with unipolar depression. Am J Psychiatry 140:877–879PubMed

241.

Tarullo AR, Gunnar MR (2006) Child maltreatment and the developing HPA axis. Horm Behav 50:632–639PubMedCrossRef

242.

Temoche A, Pugh TF, Macmahon B (1964) Suicide rates among current and former mental institution patients. J Nerv Ment Dis 138:124–130PubMedCrossRef

243.

Terao T, Yoshimura R, Ohmori O, Takano T, Takahashi N, Iwata N, Suzuki T, Abe K (1997) Effect of serum cholesterol levels on meta-chlorophenylpiperazine-evoked neuroendocrine responses in healthy subjects. Biol Psychiatry 41:974–978PubMedCrossRef

244.

Timpl P, Spanagel R, Sillaber I, Kresse A, Reul JM, Stalla GK, Blanquet V, Steckler T, Holsboer F, Wurst W (1998) Impaired stress response and reduced anxiety in mice lacking a functional corticotropin-releasing hormone receptor 1. Nat Genet 19:162–166PubMedCrossRef

245.

Traskman-Bendz L, Asberg M, Nordstrom P, Stanley M (1989) Biochemical aspects of suicidal behavior. Prog Neuropsychopharmacol Biol Psychiatry 13(Suppl):S35–S44PubMedCrossRef

246.

Traskman-Bendz L, Ekman R, Regnell G, Ohman R (1992) HPA-related CSF neuropeptides in suicide attempters. Eur Neuropsychopharmacol 2:99–106PubMedCrossRef

247.

Trivedi MH, Hollander E, Nutt D, Blier P (2008) Clinical evidence and potential neurobiological underpinnings of unresolved symptoms of depression. J Clin Psychiatry 69:246–258PubMedCrossRef

248.

Tsuang MT, Woolson RF (1977) Mortality in patients with schizophrenia, mania, depression and surgical conditions. A comparison with general population mortality. Br J Psychiatry 130:162–166PubMedCrossRef

249.

Turek FW, Van Reeth O (1995) Circadian rhythms. In: Freegly MJ, Blatteis CM (eds) Handbook of physiology: adaptation to the environment. Oxford University Press, New York, pp 1329–1359

250.

van Bemmel AL, van Diest R, Smeets EH, van Dongen PH, Hilgersom AJ (1988) Seasonal variation of cortisol plasma levels in depressives. J Affect Disord 15:191–193PubMedCrossRef

251.

van Praag HM (1986) Affective disorders and aggression disorders: evidence for a common biological mechanism. Suicide Life Threat Behav 16:103–132PubMed

252.

van Praag HM, Kahn RS, Asnis GM, Wetzler S, Brown SL, Bleich A, Korn ML (1987) Denosologization of biological psychiatry or the specificity of 5-HT disturbances in psychiatric disorders. J Affect Disord 13:1–8PubMedCrossRef

253.

Van Reeth O, Mennuni G, Maccari S (2006) Implication of melatonergic and serotonergic receptors in depression: pharmacologic treatment outcomes. In: Kasper S (ed) A new pharmacological approach to the treatment of major depression. Elsevier, Paris, pp 129–138

254.

van West D, Van Den Eede F, Del-Favero J, Souery D, Norrback KF, Van Duijn C, Sluijs S, Adolfsson R, Mendlewicz J, Deboutte D, Van Broeckhoven C, Claes S (2006) Glucocorticoid receptor gene-based SNP analysis in patients with recurrent major depression. Neuropsychopharmacology 31:620–627PubMedCrossRef

255.

Virkkunen M (1985) Urinary free cortisol secretion in habitually violent offenders. Acta Psychiatr Scand 72:40–44PubMedCrossRef

256.

Voracek M, Vintila M, Fisher ML, Yip PS (2002) Evidence for lack of change in seasonality of suicide from Timis County, Romania. Percept Mot Skills 94:1071–1078PubMed

257.

Warren CW, Smith JC, Tyler CW (1983) Seasonal variation in suicide and homicide: a question of consistency. J Biosoc Sci 15:349–356PubMedCrossRef

258.

Wasserman D (2001) Suicide - an unnecessary death. Martin Dunitz Publishers, London

259.

Wasserman D, Geijer T, Sokolowski M, Rozanov V, Wasserman J (2007) Genetic variation in the hypothalamic-pituitary-adrenocortical axis regulatory factor, T-box 19, and the angry/hostility personality trait. Genes Brain Behav 6:321–328PubMedCrossRef

260.

Wasserman D, Geijer T, Sokolowski M, Rozanov V, Wasserman J (2007) Nature and nurture in suicidal behavior, the role of genetics: some novel findings concerning personality traits and neural conduction. Physiol Behav 92:245–249PubMedCrossRef

261.

Wasserman D, Sokolowski M, Rozanov V, Wasserman J (2008) The CRHR1 gene: a marker for suicidality in depressed males exposed to low stress. Genes Brain Behav 7:14–19PubMed

262.

Watson S, Gallagher P, Del-Estal D, Hearn A, Ferrier IN, Young AH (2002) Hypothalamic-pituitary-adrenal axis function in patients with chronic depression. Psychol Med 32:1021–1028PubMedCrossRef

263.

Watzka M, Bidlingmaier F, Beyenburg S, Henke RT, Clusmann H, Elger CE, Schramm J, Klingmuller D, Stoffel-Wagner B (2000) Corticosteroid receptor mRNA expression in the brains of patients with epilepsy. Steroids 65:895–901PubMedCrossRef

264.

Weber B, Lewicka S, Deuschle M, Colla M, Vecsei P, Heuser I (2000) Increased diurnal plasma concentrations of cortisone in depressed patients. J Clin Endocrinol Metab 85:1133–1136PubMedCrossRef

265.

Weber-Hamann B, Werner M, Hentschel F, Bindeballe N, Lederbogen F, Deuschle M, Heuser I (2006) Metabolic changes in elderly patients with major depression: evidence for increased accumulation of visceral fat at follow-up. Psychoneuroendocrinology 31:347–354PubMedCrossRef

266.

Webster MJ, Knable MB, O’Grady J, Orthmann J, Weickert CS (2002) Regional specificity of brain glucocorticoid receptor mRNA alterations in subjects with schizophrenia and mood disorders. Mol Psychiatry 7:985–994 924PubMedCrossRef

267.

Wehr TA, Rosenthal NE (1989) Seasonality and affective illness. Am J Psychiatry 146:829–839PubMed

268.

Westlund KN, Aguilera G, Childs GV (1985) Quantification of morphological changes in pituitary corticotrophs produced by in vivo corticotropin-releasing factor stimulation and adrenalectomy. Endocrinology 116:439–445PubMedCrossRef

269.

Westrin A, Nimeus A (2003) The dexamethasone suppression test and CSF-5-HIAA in relation to suicidality and depression in suicide attempters. Eur Psychiatry 18:166–171PubMedCrossRef

270.

Westrin A, Ekman R, Regnell G, Traskman-Bendz L (2001) A follow up study of suicide attempters: increase of CSF-somatostatin but no change in CSF-CRH. Eur Neuropsychopharmacol 11:135–143PubMedCrossRef

271.

Wirz-Justice A, Benedetti F, Berger M, Lam RW, Martiny K, Terman M, Wu JC (2005) Chronotherapeutics (light and wake therapy) in affective disorders. Psychol Med 35:939–944PubMedCrossRef

272.

Won JG, Orth DN (1990) Roles of intracellular and extracellular calcium in the kinetic profile of adrenocorticotropin secretion by perifused rat anterior pituitary cells. I. Corticotropin-releasing factor stimulation. Endocrinology 126:849–857PubMedCrossRef

273.

Won JG, Oki Y, Orth DN (1990) Roles of intracellular and extracellular calcium in the kinetic profile of adrenocorticotropin secretion by perifused rat anterior pituitary cells. II. Arginine vasopressin, oxytocin, and angiotensin-II stimulation. Endocrinology 126:858–868PubMedCrossRef

274.

Won JG, Nicholson WE, Ching KN, Orth DN (1993) Effect of protein kinase-C depletion on inositol trisphosphate-mediated and cyclic adenosine 3′,5′-monophosphate-dependent protein kinase-mediated adrenocorticotropin secretion. Endocrinology 133:1274–1283PubMedCrossRef

275.

Woolley CS, Gould E, Sakai RR, Spencer RL, McEwen BS (1991) Effects of aldosterone or RU28362 treatment on adrenalectomy-induced cell death in the dentate gyrus of the adult rat. Brain Res 554:312–315PubMedCrossRef

276.

Xing GQ, Russell S, Webster MJ, Post RM (2004) Decreased expression of mineralocorticoid receptor mRNA in the prefrontal cortex in schizophrenia and bipolar disorder. Int J Neuropsychopharmacol 7:143–153PubMedCrossRef

277.

Yerevanian BI, Olafsdottir H, Milanese E, Russotto J, Mallon P, Baciewicz G, Sagi E (1983) Normalization of the dexamethasone suppression test at discharge from hospital. Its prognostic value. J Affect Disord 5:191–197PubMedCrossRef

278.

Yerevanian BI, Feusner JD, Koek RJ, Mintz J (2004) The dexamethasone suppression test as a predictor of suicidal behavior in unipolar depression. J Affect Disord 83:103–108PubMedCrossRef

279.

Yip PS, Chao A, Chiu CW (2000) Seasonal variation in suicides: diminished or vanished. Experience from England, Wales, 1982–1996. Br J Psychiatry 177:366–369PubMedCrossRef

280.

Young EA, Aggen SH, Prescott CA, Kendler KS (2000) Similarity in saliva cortisol measures in monozygotic twins and the influence of past major depression. Biol Psychiatry 48:70–74PubMedCrossRef

281.

Young EA, Lopez JF, Murphy-Weinberg V, Watson SJ, Akil H (2003) Mineralocorticoid receptor function in major depression. Arch Gen Psychiatry 60:24–28PubMedCrossRef

282.

Zobel AW, Nickel T, Sonntag A, Uhr M, Holsboer F, Ising M (2001) Cortisol response in the combined dexamethasone/CRH test as predictor of relapse in patients with remitted depression. A prospective study. J Psychiatr Res 35:83–94PubMedCrossRef

Titel: The hypothalamic-pituitary-adrenal axis and serotonin abnormalities: a selective overview for the implications of suicide prevention
verfasst von: Maurizio Pompili
Gianluca Serafini
Marco Innamorati
Anne Maria Möller-Leimkühler
Giancarlo Giupponi
Paolo Girardi
Roberto Tatarelli
David Lester
Publikationsdatum: 01.12.2010
Verlag: Springer-Verlag
Erschienen in: European Archives of Psychiatry and Clinical Neuroscience / Ausgabe 8/2010
Print ISSN: 0940-1334
Elektronische ISSN: 1433-8491
DOI: https://doi.org/10.1007/s00406-010-0108-z

Update Psychiatrie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Live-Webinar "Urologie und Sexualmedizin in der Praxis"

Springer Medizin

The hypothalamic-pituitary-adrenal axis and serotonin abnormalities: a selective overview for the implications of suicide prevention

Abstract

Neu im Fachgebiet Psychiatrie

Hörschwäche erhöht Demenzrisiko unabhängig von Beta-Amyloid

So wirken verschiedene Alkoholika auf den Blutdruck

„Übersichtlicher Wegweiser“: Lauterbachs umstrittener Klinik-Atlas ist online

ADHS-Medikation erhöht das kardiovaskuläre Risiko

Update Psychiatrie

Live-Webinar "Urologie und Sexualmedizin in der Praxis"

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 8/2010

Nightmare frequency and nightmare topics in a representative German sample

Thalamic volumes in patients with bipolar disorder

No association between prepulse inhibition of the startle reflex and neuropsychological deficit in chronic schizophrenia

Impaired semantic memory in the formation and maintenance of delusions post-traumatic brain injury: a new cognitive model of delusions

Do people with mental illness deserve what they get? Links between meritocratic worldviews and implicit versus explicit stigma

Sleep, hypothalamus, and stigma

Neu im Fachgebiet Psychiatrie

Hörschwäche erhöht Demenzrisiko unabhängig von Beta-Amyloid

So wirken verschiedene Alkoholika auf den Blutdruck

„Übersichtlicher Wegweiser“: Lauterbachs umstrittener Klinik-Atlas ist online

ADHS-Medikation erhöht das kardiovaskuläre Risiko

Update Psychiatrie